Aurobindo Pharma Ltd Ramipril Export Data — India (DGFT 2022–2026)

Name: Aurobindo Pharma Ltd Ramipril Export Records India — #3 Exporter, 811 Shipments, $13.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ramipril

India Pharmaceutical Trade Intelligence

$89.8M177 Suppliers93 CountriesHS 30049071

ExportsIndia → UNITED KINGDOM35.0%India → FRANCE23.2%

ImportsMALTA → India$520.7K GERMANY → India$469.4K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: CSP VIATRIS

Aurobindo Pharma Ltd — Ramipril Exporter #3 | $13.3M Trade Value | TransData Nexus | TransData Nexus

Aurobindo Pharma Ltd — Ramipril Exporter Profile

Indian Pharmaceutical Exporter · #3 for Ramipril · $13.3M export value · DGFT Verified

Aurobindo Pharma Ltd is the #3 Indian exporter of Ramipril with $13.3M in export value and 811 verified shipments. Aurobindo Pharma Ltd holds a 14.8% market share in Ramipril exports across 8 countries.

Aurobindo Pharma Ltd — Ramipril Export Profile: Buyers & Destinations

Aurobindo Pharma Ltd Ramipril export treemap — buyers and destination countries | TransData Nexus

Where Does Aurobindo Pharma Ltd Export Ramipril?

Country	Value	Shipments	Share
UNITED STATES	$7.2M	387	56.8%
UNITED KINGDOM	$1.7M	127	13.7%
MALTA	$1.7M	366	13.2%
SPAIN	$831.6K	26

Who Are the Top Buyers of Ramipril from Aurobindo Pharma Ltd?

Buyer	Country	Value	Orders
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$1.2M	46
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$1.2M	257
RISING PHARMA HOLDINGS, INC.	UNITED STATES	$893.6K	63
RISING PHARMA HOLDINGS INC	UNITED STATES	$861.6K	30
MILPHARM LIMITED,	UNITED KINGDOM	$802.4K	52
AUROLOGISTICS LLC (AUROBINDO PHARMA	UNITED STATES	$712.2K	41
AUROLOGISTICS LLC	UNITED STATES	$666.5K	32
RISING PHARMA HOLDINGS, INC. ,.	UNITED STATES	$580.9K	28
AUROLOGISTICS LLC AUROBINDO PHARM	UNITED STATES	$563.9K	23
RISING PHARMA HOLDINGS, INC. ,	UNITED STATES	$487.9K	34

Aurobindo Pharma Ltd supplies Ramipril to 54 buyers globally. The largest buyer is AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), followed by APL SWIFT SERVICES (MALTA) LTD., (MALTA) and RISING PHARMA HOLDINGS, INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ramipril Formulations Does Aurobindo Pharma Ltd Export?

Product Description / Formulation	Value	Shipments
RAMIPRIL CAPSULES 10 MG (5760X500'S)	$200.0K	4
RAMIPRIL 5 MG TABLETS (RAMIPRIL CINFA 5MG COMPRIMIDOS EFG) 28'S	$179.1K	6
RAMIPRIL CAPSULES 5.0 MG (RAMIPRIL CAPSU	$165.6K	8
RAMIPRIL CAPSULES 2.5 MG(RAMIPRIL 2.5MG	$157.1K	4
RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSULES USP 10 MG) 500"S (19121 X 500'S PACK= 9560500 NO'S)NOS	$150.0K	3
RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSUL	$149.9K	3
RAMIPRIL CAPSULES 10 MG(17328X500'S)NOS	$148.1K	3
RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSULES USP 10 MG) 500'S	$142.0K	3
RAMIPRIL CAPSULES 1.25 MG(RAMIPRIL 1.25M	$126.9K	7
RAMIPRIL CAPSULES 10 MG(RAMIPRIL 10MG CA	$126.0K	5

Aurobindo Pharma Ltd exports 603 distinct Ramipril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RAMIPRIL CAPSULES 10 MG (5760X500'S) with 4 shipments worth $200.0K.

How Does Aurobindo Pharma Ltd Compare to Nearest Ramipril Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$16.0M	320	5	$50.0K
2	GENO PHARMACEUTICALS PRIVATE LIMITED	$14.0M	686	1	$20.5K
3	AUROBINDO PHARMA LTD ★	$13.3M	811	8	$16.4K
5	IND SWIFT LIMITED	$6.4M	307	3	$20.8K
6	ZENTIVA PRIVATE LIMITED	$4.9M	233	5	$21.0K

Aurobindo Pharma Ltd ranks #3 among 177 Indian Ramipril exporters. Average shipment value of $16.4K compared to the market average of $466.2K. The closest competitors by value are MYLAN LABORATORIES LIMITED and GENO PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Ramipril Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	658	13.2%
JNPT/ NHAVA SHEVA SEA	553	11.1%
SAHAR AIR CARGO ACC (INBOM4)	305	6.1%
SAHAR AIR	291	5.8%
JNPT	271	5.4%
DELHI AIR CARGO ACC (INDEL4)	214	4.3%
DELHI AIR	201	4.0%
VIZAG SEA	194	3.9%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,087 individual customs records matching Aurobindo Pharma Ltd exporting Ramipril, covering 603 formulations to 9 countries via 54 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 93+ countries, 389+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ramipril

Ramipril

Aurobindo Pharma Ltd — Ramipril Exporter Profile

Aurobindo Pharma Ltd — Ramipril Export Profile: Buyers & Destinations

Where Does Aurobindo Pharma Ltd Export Ramipril?

Who Are the Top Buyers of Ramipril from Aurobindo Pharma Ltd?

What Is India's Total Ramipril Export Value and How Much Does Aurobindo Pharma Ltd Contribute?

What Is the Average Shipment Value for Aurobindo Pharma Ltd's Ramipril Exports?

How Does Aurobindo Pharma Ltd Compare to Other Indian Ramipril Exporters?

What Ramipril Formulations Does Aurobindo Pharma Ltd Export?

Regulatory Requirements: Exporting Ramipril to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Aurobindo Pharma Ltd Compare to Nearest Ramipril Exporters?

Which Indian Ports Ship Ramipril Exports?

Ramipril — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ramipril Export Data from Aurobindo Pharma Ltd

Ramipril Stats

Related Analysis

Need Detailed Export Data?

Data Source